A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
The purpose of the study is to evaluate dose response of blood pressure lowering for 4 doses of AHU377, given once daily (50 mg, 100 mg, 200 mg and 400 mg) in combination with a fixed dose of valsartan (320 mg).
Inclusion Criteria:
Exclusion Criteria:
Buenos Aires, Buenos Aires C1120AAC, Argentina
Caba, Buenos Aires C1440AAD, Argentina
Caba, Buenos Aires F.D. C1179AAB, Argentina
Ste-Foy, Quebec G1V 4G2, Canada
Nyiregyháza, 4400, Hungary
Koyang, Kyunggi 410-719, South Korea